Ethics and practice: alternative designs for phase III randomized clinical trials.

Area of Science:

• Biostatistics
• Clinical Trial Methodology
• Medical Ethics

Background:

• Traditional clinical trial designs use fixed sample sizes and equal allocation.
• Alternative designs, like sequential and adaptive trials, offer ethical and participant representation benefits.
• Despite advances, these data-dependent designs are not widely adopted in practice.

Purpose of the Study:

• To identify conditions where alternative clinical trial designs are feasible and desirable.
• To examine the ethical considerations, both individual and collective, in clinical trial design.
• To encourage greater consideration of alternative designs in phase III clinical trials.

Main Methods:

• Review of methodologies for clinical trials, focusing on data-dependent designs.
• Analysis of ethical and logistical factors influencing design choices.
• Case examples of implemented alternative designs, evaluating their strengths and weaknesses.

Main Results:

• Alternative designs, including sequential, Bayesian, and adaptive methods, are ethically advantageous.
• Feasibility and desirability depend on specific ethical and logistical contexts.
• Current adoption rates for these advanced designs remain low.

Conclusions:

• Alternative clinical trial designs are suitable for specific trial categories.
• Increased awareness and consideration of these designs are recommended during trial planning.
• Greater emphasis on individual ethics can guide the selection of appropriate trial designs.